GI
BNTX icon

Gradient Investments’s BioNTech BNTX Stock Holding History

Gradient Investments’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-32
Closed -$3.45K – 1818
2023
Q2 		$3.45K Buy
+32
New +$3.6K ﹤0.01% 1041
2021
Q1 		– Sell
-100
Closed -$7K – 1156
2020
Q4 		$7K Hold
100
– – ﹤0.01% 751
2020
Q3 		$7K Buy
+100
New +$7.17K ﹤0.01% 757

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

Gradient Investments's BNTX Position: Q3 2023 in Review

Gradient Investments sold out of BioNTech (BNTX) in Q3 2023, closing a stake of 32 shares — an estimated $3.45K sold.

Gradient Investments first reported a position in BNTX in Q3 2020 and held it in 3 quarters. The position peaked at $7K in Q4 2020. 252 funds tracked by Wall St. Rank hold BNTX as of Q3 2023.

  • Gradient Investments reported no remaining BioNTech position as of Q3 2023 after selling out during the quarter.
  • Gradient Investments sold 32 BioNTech shares in Q3 2023, an estimated $3.45K.
  • Gradient Investments first reported a position in BioNTech in Q3 2020 and held it in 3 quarters.
  • Gradient Investments's BioNTech position peaked at $7K in Q4 2020.
  • 252 funds tracked by Wall St. Rank held BioNTech as of Q3 2023.

Based on Gradient Investments's 13F filing for Q3 2023, filed 27 Oct 2023.